Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
cytomegalovirus retinitis
MeSH D017726 - cytomegalovirus retinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003586:
Cytomegalovirus infections
35 Companies
6 Drugs
$
Success rate
D015828:
Viral eye infections
0 Companies
0 Drugs
Success rate
D012173:
Retinitis
0 Companies
0 Drugs
Success rate
D017726:
Cytomegalovirus retinitis
29 Companies
4 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
83
%
5/6
Phase 2
71
%
5/7
Phase 3
73
%
11/15
Approved:
7
Overall Success rate:
44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Ganciclovir
,
Interferon beta
,
Cilmostim
,
Regramostim
,
Molgramostim
,
Sagramostim
Bausch Health Companies
Ganciclovir
Dr Reddys Laboratories
Valganciclovir
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use